Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pacific Biosciences of California, Inc. - Common Stock
(NQ:
PACB
)
1.740
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacific Biosciences of California, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday
↗
April 09, 2025
Via
Benzinga
Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks
April 09, 2025
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Assessing Pacific Biosciences: Insights From 6 Financial Analysts
↗
March 25, 2025
Via
Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
↗
March 22, 2025
Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.
Via
Benzinga
Where Pacific Biosciences Stands With Analysts
↗
February 18, 2025
Via
Benzinga
Earnings Scheduled For February 13, 2025
↗
February 13, 2025
Via
Benzinga
3 Reasons to Sell PACB and 1 Stock to Buy Instead
March 18, 2025
Shareholders of PacBio would probably like to forget the past six months even happened. The stock dropped 35.2% and now trades at $1.25. This was partly due to its softer quarterly results and might...
Via
StockStory
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks
March 17, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
Via
StockStory
Topics
Artificial Intelligence
1 Healthcare Stock to Target This Week and 2 to Turn Down
March 11, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...
Via
StockStory
Topics
Stocks
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
↗
February 14, 2025
Via
Benzinga
What Analysts Are Saying About Pacific Biosciences Stock
↗
January 23, 2025
Via
Benzinga
PacBio (NASDAQ:PACB) Misses Q4 Sales Targets
February 13, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 32.8% year on year to $39.22 million. Its non-GAAP loss of...
Via
StockStory
PacBio (PACB) Q4 Earnings Report Preview: What To Look For
February 12, 2025
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market hours. Here’s what investors should know.
Via
StockStory
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
January 07, 2025
With Ark Invest ending 2024 on a strong note, the aggressive growth icon is hoping to build on that momentum in 2025.
Via
The Motley Fool
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight
↗
December 05, 2024
Cathie Wood is investing in PacBio, a biotech company with potential for genomics revolution. ARK Invest is confident in its long-term growth.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 04, 2024
Via
Benzinga
What 5 Analyst Ratings Have To Say About Pacific Biosciences
↗
August 28, 2024
Via
Benzinga
Analyst Scoreboard: 5 Ratings For Pacific Biosciences
↗
August 12, 2024
Via
Benzinga
Deciphering Disruption: Inside Cathie Wood's Latest Plays
November 16, 2024
Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
November 12, 2024
The rock star money manager is starting to roll with the rallying market.
Via
The Motley Fool
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
November 08, 2024
Via
Benzinga
Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
October 14, 2024
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
↗
October 14, 2024
Via
Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
↗
October 11, 2024
Via
Benzinga
Topics
Stocks
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
↗
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 11, 2024
Via
Benzinga
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
↗
October 11, 2024
Via
Benzinga
A Biotech Breakout Will Be Led By Small Caps
↗
September 23, 2024
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.
Via
Talk Markets
Topics
Artificial Intelligence
Economy
Quanex Building Products Posts Better-Than-Expected Results, Joins Zumiez, Guidewire Software, Smartsheet And Other Big Stocks Moving Higher On Friday
↗
September 06, 2024
Via
Benzinga
Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
August 16, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.